clopidogrel has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbosh, PH; Chen, DY; Derweesh, IH; Ginzburg, S; Greenberg, RE; Hamilton, Z; Ito, T; Kutikov, A; Mirheydar, H; Raheem, OA; Smaldone, MC; Uzzo, RG; Viterbo, R | 1 |
| Akgün, T; Can, MM; Karabay, CY; Kaymaz, C; Ozveren, O; Serebruany, V; Tanboğa, IH; Tokgöz, HC; Türkyilmaz, E | 1 |
2 other study(ies) available for clopidogrel and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy.
Topics: Age Factors; Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Carcinoma, Renal Cell; Clopidogrel; Coronary Thrombosis; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Patient Readmission; Perioperative Period; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Late common iliac artery stent thrombosis in a patient with terminal malignancy.
Topics: Aged; Angiography; Aspirin; Atherosclerosis; Carcinoma, Renal Cell; Clopidogrel; Humans; Iliac Artery; Kidney Neoplasms; Male; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2010 |